It mediates the Lys48-linked polyubiquitination of the Lys233 residue in the cytoplasmic domain of PD-1 protein and subsequent proteasome degradation [20,21], thus downregulating the surface PD-1 expression and blocking tumor immune escape mediated by PD-1/PD-L1. This evidence concerns the gene PDCD1 and neoplasm.